Tradewinds Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Tradewinds Capital Management’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13	Closed	-$10	–	768
2026 Q1	$10	Hold	13	–	–	﹤0.01%	714
2025 Q4	$70	Hold	13	–	–	﹤0.01%	661
2025 Q3	$93	Hold	13	–	–	﹤0.01%	654
2025 Q2	$96	Hold	13	–	–	﹤0.01%	611
2025 Q1	$239	Hold	13	–	–	﹤0.01%	618
2024 Q4	$453	Buy	+13	New	+$362	﹤0.01%	597

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Tradewinds Capital Management's RVPH Position: Q2 2026 in Review

Tradewinds Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 13 shares — an estimated $10 sold.

Tradewinds Capital Management first reported a position in RVPH in Q4 2024 and held it in 6 quarters. The position peaked at $453 in Q4 2024. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Tradewinds Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Tradewinds Capital Management sold 13 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $10.
Tradewinds Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2024 and held it in 6 quarters.
Tradewinds Capital Management's REVIVA PHARMA HLDGS INC position peaked at $453 in Q4 2024.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.